Aptevo Therapeutics(APVO) - 2023 Q4 - Annual Report

th | --- | --- | --- | |------------------------------------------------------|------------------|-----------------------------------------------------------------------| | Title of Each Class | Trading Symbol | Name of Exchange on Which Registered | | Common Stock, $0.001 par value per share | APVO | The Nasdaq Stock Market LLC (The Nasdaq Capital Market) | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC ...